Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Steg

Showing results (131-140 of 1,111) with videos related to

Pageof 112
Sort By:
American Heart Journal|February 15, 2011
The influence of time from symptom onset and reperfusion strategy on 1-year survival in ST-elevation myocardial infarction: a pooled analysis of an early fibrinolytic strategy versus primary percutaneous coronary intervention from CAPTIM and WESTCynthia M Westerhout, Eric Bonnefoy, Robert C Welsh, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|July 8, 2010
Differences in management and outcomes between male and female patients with atherothrombotic disease: results from the REACH Registry in EuropeJonathan Morrell, Uwe Zeymer, Iris Baumgartner, et al.
Circulation. Cardiovascular Quality and Outcomes|December 24, 2015
Quality of Life With Ivabradine in Patients With Angina Pectoris: The Study Assessing the Morbidity-Mortality Benefits of the If Inhibitor Ivabradine in Patients With Coronary Artery Disease Quality of Life SubstudyMichal Tendera, Olivier Chassany, Roberto Ferrari, et al.
The American Journal of Medicine|August 5, 2006
Predischarge C-reactive protein and 1-year outcome after acute coronary syndromesPhilippe Gabriel Steg, Philippe Ravaud, Alain Tedgui, et al.
Chest|July 24, 2008
Acute ST-segment elevation myocardial infarction: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Shaun G Goodman, Venu Menon, Christopher P Cannon, et al.
The American Journal of Medicine|July 24, 2017
Unreliable Observations from a Confounded Analysis of a Skewed DatabasePhilippe Gabriel Steg, Robert A Harrington, Anders Himmelmann, et al.
International Journal of Cardiology|March 20, 2010
Development and validation of a bleeding risk model for patients undergoing elective percutaneous coronary interventionGilles Montalescot, Genevieve Salette, Gabriel Steg, et al.
American Heart Journal|June 23, 2009
Renal function, atherothrombosis extent, and outcomes in high-risk patientsRaphaelle L Dumaine, Gilles Montalescot, Ph Gabriel Steg, et al.
JACC. Cardiovascular Interventions|March 25, 2017
Long-Term Outcomes of Stenting the Proximal Left Anterior Descending Artery in the PROTECT TrialAriel Roguin, Edoardo Camenzind, Arthur Kerner, et al.
Circulation|April 25, 2024
Comparison of Incidence and Prognostic Impact of Ischemic, Major Bleeding and Heart Failure Events in Patients With Chronic Coronary Syndrome: Insights From the CORONOR RegistryGilles Lemesle, Nicolas Lamblin, Guillaume Schurtz, et al.
Pageof 112

Showing results (131-140 of 1,111) with videos related to

Sort By:
Pageof 112
American Heart Journal|February 15, 2011
The influence of time from symptom onset and reperfusion strategy on 1-year survival in ST-elevation myocardial infarction: a pooled analysis of an early fibrinolytic strategy versus primary percutaneous coronary intervention from CAPTIM and WESTCynthia M Westerhout, Eric Bonnefoy, Robert C Welsh, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|July 8, 2010
Differences in management and outcomes between male and female patients with atherothrombotic disease: results from the REACH Registry in EuropeJonathan Morrell, Uwe Zeymer, Iris Baumgartner, et al.
Circulation. Cardiovascular Quality and Outcomes|December 24, 2015
Quality of Life With Ivabradine in Patients With Angina Pectoris: The Study Assessing the Morbidity-Mortality Benefits of the If Inhibitor Ivabradine in Patients With Coronary Artery Disease Quality of Life SubstudyMichal Tendera, Olivier Chassany, Roberto Ferrari, et al.
The American Journal of Medicine|August 5, 2006
Predischarge C-reactive protein and 1-year outcome after acute coronary syndromesPhilippe Gabriel Steg, Philippe Ravaud, Alain Tedgui, et al.
Chest|July 24, 2008
Acute ST-segment elevation myocardial infarction: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Shaun G Goodman, Venu Menon, Christopher P Cannon, et al.
The American Journal of Medicine|July 24, 2017
Unreliable Observations from a Confounded Analysis of a Skewed DatabasePhilippe Gabriel Steg, Robert A Harrington, Anders Himmelmann, et al.
International Journal of Cardiology|March 20, 2010
Development and validation of a bleeding risk model for patients undergoing elective percutaneous coronary interventionGilles Montalescot, Genevieve Salette, Gabriel Steg, et al.
American Heart Journal|June 23, 2009
Renal function, atherothrombosis extent, and outcomes in high-risk patientsRaphaelle L Dumaine, Gilles Montalescot, Ph Gabriel Steg, et al.
JACC. Cardiovascular Interventions|March 25, 2017
Long-Term Outcomes of Stenting the Proximal Left Anterior Descending Artery in the PROTECT TrialAriel Roguin, Edoardo Camenzind, Arthur Kerner, et al.
Circulation|April 25, 2024
Comparison of Incidence and Prognostic Impact of Ischemic, Major Bleeding and Heart Failure Events in Patients With Chronic Coronary Syndrome: Insights From the CORONOR RegistryGilles Lemesle, Nicolas Lamblin, Guillaume Schurtz, et al.
Pageof 112